| Literature DB >> 8343632 |
R J Howard1, C Lillis, S M Tuck.
Abstract
Sickle cell disease is listed in the manufacturers' data sheets in the United Kingdom as a contraindication to the use of most combined contraceptive pills; the result is confused advice on family planning to a group of women who are at substantial risk from both planned and unplanned pregnancy. A study in north London on the use of contraceptives by women with sickle cell disease indicates that the use of combined oral contraceptives is common. Although medical staff usually advised against pregnancy, such advice was almost always ignored. Over half of the women surveyed had some knowledge about antenatal diagnosis. Family planning advice should be an integral part of the care of women with sickle cell disease. In the absence of specific data to the contrary all methods of contraception may be considered, although with appropriate caution.Entities:
Keywords: Clinic Activities; Contraception; Contraceptive Methods; Contraceptive Usage--women; Counseling; Data Aggregation; Developed Countries; Diseases; Europe; Family Planning; Genetic Counseling; Hereditary Diseases; Morbidity--women; Northern Europe; Oral Contraceptives; Organization And Administration; Program Activities; Programs; Research Methodology; United Kingdom
Mesh:
Substances:
Year: 1993 PMID: 8343632 PMCID: PMC1678269 DOI: 10.1136/bmj.306.6894.1735
Source DB: PubMed Journal: BMJ ISSN: 0959-8138